Literature DB >> 22678377

The gatekeepers of effectiveness.

Mark Ratner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22678377     DOI： 10.1038/nbt.2265

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.

Authors:  Junya Zhu; Dhruv B Sharma; Stacy W Gray; Aileen B Chen; Jane C Weeks; Deborah Schrag
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272
  1 in total
  1 in total

1.  Amgen best-seller challenged by generics.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.